Introduction {#s1}
============

Much attention has recently been paid to a new group of effective cancer genes, so-called cancer/testis genes. Cancer-testis antigens (CTAs) are a group of tumor-related antigens (Ags) (e.g., *NY-ESO-1, SSX1, HOM-TES-85, TSGA10, AKAP4, ODF4, PIWIL2*, and *RHOXF2*), which are profoundly overexpressed in the testis and different tumor sites, while they show limited expression in the normal cells/tissues.^[@R1]-[@R4]^ It has been shown that the expression of these Ags is controlled epigenetically.^[@R5]^ *TSGA10* is a newly identified member of this gene family, which contributes to the cell division, differentiation, and migration.^[@R6]^ It is expressed in the testis during the progressive stages of embryogenesis, spermatogenesis, and also in some solid tumors such as breast cancer.^[@R7]^ It has been proposed that *TSGA10* plays a key role in the proliferating and survival of the breast cancer cells. The *TSGA10* gene encodes a soluble protein, which is not a membrane protein.^[@R8],[@R9]^ It is expressed in small amounts in the undifferentiated embryonic stem cells. On the other hand, during entering a cell into the mitosis phase, the *TSGA10* level is increased up to 6-fold, indicating its role in the cell division process.^[@R10]^ In a number of studies, the expression of *TSGA10* gene was shown to be low in the normal cells,^[@R11],[@R12]^ while its expression appears to be high, therefore this molecular marker is considered as a candidate tumor suppressor gene. Tumor microenvironment (TME) is a heterogeneous milieu composed of several types of cancerous and non-cancerous cells,^[@R13],[@R14]^ and shows unique characteristics, including anomalous metabolism of energetic pathways (e.g., glucose) together with irregular metabolisms of amino acids (e.g., L-tryptophan), pH dysregulation, and hypoxia.^[@R15],[@R16]^ The main reason for the pH dysregulation in TME is the increased glycolysis rather than oxidative phosphorylation (the so-called Warburg effect).^[@R15]^ According to this pathobiological phenomenon, the intracellular pH (pH~i~) is increased from \~ 7.2 to about 7.4, and extracellular pH (pH~e~) is reduced from approximately 7.4 to \~ 6.7-7.1.^[@R17]^ Further, hypoxia-inducible factor 1-alpha (HIF-1α) is one of the important transcription factors (TFs) that intervene with several critical cellular functions during hypoxia, including cellular responses to the hypoxia, glycolytic cycle, angiogenesis, migration, invasion, and metastasis of malignant cells.^[@R15],[@R16],[@R18]^ In this case, HIF-1α acts as an architecture in some cellular signaling pathways, including (i) *PI3K/AKT* and *MAPK*, (ii) reduction of the function of tumor-suppressor genes (e.g., *VHL, PTEN*, and *CDKN2A*), and in contrast, (iii) increasing the activity of some oncogenes (e.g., *RAS, SRC, BCR-ABL, TWIST1,* and *MET*).^[@R19]-[@R21]^ Furthermore, recent researches have indicated that *TSGA10* has a high affinity to interact with HIF-1α.^[@R22]^ However, the precise role of *TSGA10* in different normal and cancer cells is not still fully identified. Thus, this gene seems to be an interesting candidate biomarker for further investigations.

The use of *in silico* computational analysis and systems biology provides a robust simulation workspace for biologists on more accurate detection of the physical interactions between various bio-elements (e.g., TFs) and their regulatory relationships within different biological pathways.^[@R23]^ Among these, protein-protein interaction (PPI) networks can serve to decrypt and predict the less-known biological paths and functions.^[@R24],[@R25]^ It should be noted that the PPI networks can grant attractive topological features relative to the specific physical contacts between *TSGA10* and the other proteins involved in the breast cancer.^[@R26]^ For this reason, we first investigated the potential effects of hyperglycemia/hypoglycemia/hypoxia on *TSGA10* expression in the breast cancer MDA-MB-231 cells and also pursued the metastasis process in relation with this gene *in vitro*. Second, we studied the biochemical features, 3D structure, and subcellular localization of *TSGA10* and HIF-1α using various bioinformatic tools. We also capitalized on the docking- and network-based analysis to assess the binding affinity and interactions between *TSGA10* and HIF-1α and the other interactive oncoproteins in the related PPI network. We also introduced redesigned signaling pathways related to *TSGA10* and HIF-1α for both normoxia and hypoxia conditions.

Materials and methods {#s2}
=====================

Cell culture {#s2-1}
------------

Human breast cancer cell lines (MDA-MB-231and MCF-7) were purchased from the Iranian National Cell Bank (Pasteur Institute, Tehran, Iran). Cells were cultured in RPMI 1640 medium (Gibco, Thermo Fisher Scientific Corp., Waltham, MA, USA) containing 10% (v/v) fetal calf serum (Thermo Fisher Scientific Corp., Waltham, MA, USA) and 1% penicillin/streptomycin (Invitrogen, Thermo Fisher Scientific Corp., Waltham, MA, USA). Cells were maintained as monolayer cultures at 37ºC in a humidified 5% CO~2~ atmosphere, and cultivated using different concentrations of glucose (5.5, 11, and 25 mM) and under hypoxia (1% O~2~) to mimic the TME conditions. For the induction of hypoxia, the cultivated cells were incubated with CoCl~2~.^[@R27]^

Protein extraction and western blotting {#s2-2}
---------------------------------------

For the extraction of the total protein, the cultivated cells were lysed using the lysis buffer \[50 mM Tris (pH 7.4), 1% Triton X-100, 1% sodium 125 deoxycholate, 0.1% SDS, 150 mM NaCl, 1.0 mM EDTA, 1.0 mM Na3VO4, and inhibitor cocktail tablets\]. A designated equal amount of the total proteins extracted from different treatments was resolved on a sodium dodecyl sulfate-polyacrylamide gel (i.e., 7.5%, 12.5% polyacrylamide gels) electrophoresis (SDS-PAGE) and transferred onto the nitrocellulose membrane (Bio-Rad, Hercules, CA, USA). The membranes were incubated with the primary rabbit monoclonal anti-HIF-1α from Life Technology Invitrogen (Thermo Fisher Scientific Corp., Waltham, MA, USA). Then, they were overlaid with the secondary polyclonal goat anti-rabbit antibodies (Abcam, Cambridge, UK). The protein bands were visualized using a chemiluminescence system (Millipore, Burlington, MA, USA).

Scratch assay {#s2-3}
-------------

MDA-MB-231 and MCF-7 cells were cultivated to reach the full confluency. Then, they were scratched by the tip of the crystal pipettes and washed twice with PBS to remove the cell debris and the floating cells. The cells were then treated with different concentrations of glucose (5.5, 11, and 25 mM) under hypoxic condition (1% and 20% O~2~) for 8 h (MDA-MB-231) and 24 h (MCF-7). Images were captured at different time points after the treatment to mark and assess the changes in the migration of phenotypically modified MDA-MB-231 and MCF-7 cells. The cell distance was measured by an open source image processing software, ImageJ (National Institutes of Health, Bethesda, MD, USA). Each independent experiment was performed in replicates.

Real time-PCR {#s2-4}
-------------

Total RNA was extracted using Trizol reagent (Invitrogen, Thermo Fisher Scientific Corp., Waltham, MA, USA). Reverse transcription-PCR was performed with M-MLV (Promega, Madison, WI, USA) following a standard protocol \[65°C for 5 minutes (oligonucleotide, random hexamers, 10 mM dnTPs)\], followed by 25°C for 10 minutes, 42 °C for 60 minutes and 70°C for 10 minutes (RNase inhibitor, M-MLV, 5X buffer and H~2~O). The cDNA (1 μL) from each sample was used with SYBR Green in a thermo-cycler (Bio-Rad, Hercules, CA, USA) to perform the real-time PCR in a total volume of 20 μL. Thermal cycling condition was as follows: 1 cycle at 94°C for 10 minutes, 40 cycles at 95°C for 15 seconds, 58°C (depending on the gene) for 30 seconds, and 72°C for 25 seconds. The primers used were as follows: *TSGA10* 5\'-CAACGGCACATGCTATTCTCC-3\' (forward), 5\'-CCACAGTGCTTATGGTTTCCTTC-3\' (reverse); GAPDH 5\'-AAGCTCATTTCCTGGTATGACAACG-3\' (forward), 5\'-TCTTCCTCTTGTGCTCTTGCTGG-3\' (reverse). The relative fold change in mRNA expression was calculated using the 2^-RΔΔCt^ method. Average of ΔCt values was normalized with Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the control. The reactions were performed in triplicates.

Statistical analysis {#s2-5}
--------------------

In this study, at least three independent experiments were conducted. The data are presented as means ± SD. The data were evaluated by one-way analysis of variance (ANOVA) followed by a multiple comparison post hoc Tukey test (Graph Pad software, version 6.0, Inc., La Jolla, CA, USA). A*P* value less than 0.05 was considered statistically significant. Each point/column represents the mean value ± SD (*n*=3) (\**P*\< 0.05, \*\* *P*\<0.01).

Homology modeling, validation, and energy minimization {#s2-6}
------------------------------------------------------

The possible physical interaction between *TSGA10* and HIF-1α was evaluated based on the literature search.^[@R22]^ The PPI was simulated computationally using the molecular docking methods. The 134-amino acid domain of *TSGA10* (556-689) participated in this protein-protein interaction was modeled using MODELLER *v*4.0 software.^[@R28]^ The 3D structure of HIF-1α was obtained from the Protein Data Bank (PDB ID: 1H2M). The quality of structure modeling was assessed based on the ProSA z-score, Verify3D and ERRAT web-servers.^[@R29]-[@R31]^ The stereochemical accuracy of the models was also analyzed based on the psi/phi Torsion angles through the Ramachandran's plot using RAMPAGE server.^[@R32]^ The Swiss-PDB viewer *v*4.1.0 software was employed for the energy minimization of models.^[@R33]^

Molecular docking {#s2-7}
-----------------

The C-terminal domain of *TSGA10* was structurally minimized and prepared for the docking through the Dock Prep tool of UCSF Chimera *v*1.11 program.^[@R34]^ In this step, four main tasks were done, including (i) deleting water molecules, (ii) repairing truncated side chains, (iii) adding hydrogen atoms, and (iv) assigning partial atomic charges.^[@R35]^ The molecular docking process was performed using the Hex *v*8.0.0 software as described previously.^[@R36]^ The docking result was analyzed and visualized using LigPlot+ *v*1.4.5,^[@R37]^ and UCSF Chimera *v*1.11 programs.

Cellular localization {#s2-8}
---------------------

Intracellular and extracellular localization of *TSGA10* and HIF-1α and the main domain of *TSGA10*, which participates in the physical interaction with HIF-1α, were retrieved from the UniProtKB database. The gene ontology tool of the DAVID database was also used for the analysis of the cellular component (CC) ontology.^[@R38]^

Functional enrichment analysis {#s2-9}
------------------------------

The functional annotation was performed using the "Database for Annotation, Visualization and Integrated Discovery" (DAVID) web-server.^[@R38]^ The biological pathways and functional clustering annotation for the hub-related proteins in the PPI network was retrieved from the DAVID database. A corrected *P*-value less than 0.05 was set as the threshold for the functional classification enrichment analysis.

PPI network analysis {#s2-10}
--------------------

The proteins for possible physical interactions with *TSGA10* and HIF-1α were downloaded from the STRING database *v*10.5,^[@R39]^ and imported to the Cytoscape *v*3.6.0 for the visualization and analysis. The network statistical significance was measured using the Network Analyzer tool of the Cytoscape.^[@R40]^ The PPI network was regenerated using 57 proteins that were related to the adjacent biological processes. Further, the PPI network was generated based on the medium confidence score of 0.40 and for exploring the network data, in which all the interaction source parameters were selected, including text-mining, experiments, databases, co-expression, neighborhood, gene fusion, and co-occurrence. The topological centralities of the PPI network such as betweenness centrality, connectivity degree of nodes, the network diameter (the maximum of the shortest path lengths), the shortest path lengths between two nodes and the mean path length (the average of the shortest path lengths) were analyzed using the Network Analyzer plugin of Cytoscape. The CytoHubba plugin in Cytoscape was used for the prediction of important nodes (or hub proteins), and jActiveModule tool was used for the module detection in the PPI network.^[@R41]^ Highly interconnected sub-graphs (clusters) in the PPI network were identified using MCODE algorithm.^[@R42]^ The MCODE, as a graph clustering tool, was used based on the finding parameters, including (i) degree cutoff of 2.0, (ii) node score cutoff of 0.2, (iii) K-core of 2.0, and (iv) maximum depth of 100.

Signaling pathways reconstruction {#s2-11}
---------------------------------

The signaling pathway in relation to *TSGA10* and HIF-1α and under the normoxic and hypoxic conditions was manually reconstructed based on the PPI network analysis and also the BioModels and KEGG pathway database. The signaling pathway visualization in the form of a graphical environment was carried out via the CellDesigner *v*4.4 program.^[@R43]^

Results {#s3}
=======

It seems that the profile of *TSGA10* expression is an important factor in the initiation and development of breast cancer. Its expression in 17 cancer types is shown in Fig. S1 (see [Supplementary file 1](#Suppl1){ref-type="supplementary-material"}).

Hypoxia promotes migration in the MDA-MB-231 cells {#s3-1}
--------------------------------------------------

Cell migration was an evaluation criterion for the metastatic potential of cancer cells. To further evaluate how hypoxia and glucose concentration might promote the MDA-MB-231 and MCF-7 cells migration *in vitro*, we capitalized on the scratch assay. The confluent monolayer of cultivated cells was scratched carefully. As shown in [Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} , the cells were cultivated using two different conditions of glucose and oxygen concentrations, including the use of 5.5, 11, or 25 mM glucose either under normoxic 20% O~2~ condition (panel A) or hypoxic 1% O~2~ condition (panel B) for 8 hours (MDA-MB-231 cells) and 24 hours (MCF-7 cells). Hypoxia condition resulted in increased level of HIF-1 ([Figs. 1](#F1){ref-type="fig"} and [2C](#F2){ref-type="fig"}). The MDA-MB-231 cells under normoxic conditions showed significant increases in the migration with the increased concentration of glucose in a dose-dependent manner (5.5 mM\<11 mM\<25 mM). The hypoxic cells, however, showed decreased migration in presence of high concentrations of glucose (5.5 mM\>11 mM\>25 mM) ([Fig. 1D](#F1){ref-type="fig"}). Scratch assay results for MCF-7 cells did not differ significantly in different concentrations of glucose, normoxia, and hypoxia after 24 hours (5.5 mM\<11 mM\<25 mM) ([Fig. 2D](#F2){ref-type="fig"}). These results indicated that hypoxia and low glucose treatment of high-metastatic breast cancer MDA-MB-231 cells improved their proliferation and motility abilities, while in such situations, low-metastatic breast cancer MCF-7 cells exhibited reversible behavior. It seems that MCF-7 cells are not responsive to the hypoxia as much as MDA-MB-231 cells. These results highlight the importance of the hypoxia as an important factor in the breast cancer metastasis.
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Migration conditions reduce TSGA10 gene expression in MDA-MB-231 cells {#s3-2}
----------------------------------------------------------------------

The cultured MDA-MB-231 and MCF-7 cells treated with different concentrations of glucose and under hypoxic conditions for 24, 48 and 72 hours were investigated for the expression of *TSGA10* mRNA by real-time PCR. The over-expression of *TSGA10* mRNA in comparison with the untreated control MDA-MB-231and MCF-7 cells was observed in the MDA-MB-231 and MCF-7 cells treated with different concentrations of glucose under normoxia or hypoxia ([Fig. 3](#F3){ref-type="fig"}). In comparison with the untreated control cells, we witnessed that 24-hour hypoxia and high glucose (25 mM) increased the expression of *TSGA10* mRNA in the MDA-MB-231 cells. However, after 48 and 72 hours, the expression of *TSGA10* was increased with glucose under normoxia ([Fig. 3](#F3){ref-type="fig"}). The cells treated with 25 mM glucose under the normoxic conditions showed the highest expression after 48 hours, which was significantly reduced after 72 hours. Similarly, the cells treated with 25 mM glucose under hypoxic condition showed markedly high expression of *TSGA10* mRNA after 24 hours, which was reduced afterward indicating a radical change in the expression of the gene under high glucose level and hypoxia. To compare between the low- and high-metastatic tumor cells, we examined the expression of *TSGA10* mRNA in MCF-7 cells. Despite showing similar trends, the MCF-7 cells showed a higher adaptation to the hypoxia and low glucose concentration over the time since the level of *TSGA10* expression in such conditions showed a slight increase. Given the increased expression of *TSGA10* mRNA in the MDA-MB-231 cells, it can be concluded that this gene might act as an inhibitor of the metastasis and migration of cancer cells.
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Three-dimensional structure modeling, validation, and energy minimization {#s3-3}
-------------------------------------------------------------------------

Based on the UniProtKB database, the residue of TSGA10 (556-689) was identified as a key C-terminal domain that can closely interact with the alpha subunit of HIF-1 protein. Three-dimensional (3D) structure of this domain is shown in [Fig. 3A](#F3){ref-type="fig"}. The energy minimization value of the modeled TSGA10 was about -- 8972.120 kJ/mol. This numerical analysis decreased free energy of the modeled protein and improved its physical status.^[@R44]^ The EasyModeller provided two modeling validation scores of GA431 and DOPE, in which the model with high accuracy shows a GA341 score of \~1.0 while the model with higher negative DOPE scores is considered as a stable structure.^[@R44]^ The assessed values of GA341 and DOPE scores of the modeled TSGA10 were 1.0, and -14228.651 kcal/mole, respectively. [Table 1](#T1){ref-type="table"} represents some other estimated validation values, including ProSA z-score, ERRAT, Verify3D, and Ramachandran plot.

###### The modeling validation assays using different online web-servers

  -------------- --------------------------------------------------------------------- ----------- -----------
  **Methods**    **Assay scheme**                                                      **Score**   **Range**
  ProSA-web      Modeling verification by calculating an overall quality Z-score       \- 3.45     NPS^\*^
  ERRAT (%)      The overall quality for non-bounded atomic interactions               91.65       \>50%
  VERIFY3D (%)   The number of residues having an average 3D/1D score above 2.0        72.00       \>80%
  RAMPAGE (%)    The residues within the allowed region in psi/phi Ramachandran plot   98.60       \>90%
  -------------- --------------------------------------------------------------------- ----------- -----------

\* Native protein size (NPS): This criterion checks the z-score of the target structure whether is within the range of scores typically identified for the native proteins of similar size.

Binding affinity between TSGA10 and HIF-1α {#s3-4}
------------------------------------------

The docking energy value between the HIF-1α and *TSGA10* domain was about -698.69 kcal/mol. The molecular interactions between the binding site of HIF-1α and TSGA10 domain are shown as 3D and 2D in [Figs. 4C](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"} , respectively.
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As shown in [Fig. 5](#F5){ref-type="fig"} , thirteen residues of HIF-1α (i.e., Gly^155^, Gly^86^, Gly^88^, Val^154^, Asn^151^, Thr^149^, Thr^183^, Met^325^, Thr^302^, Ala^317^, and Lys324) were involved in the hydrophobic interactions with the *TSGA10* domain. Further, eleven residues of HIF-1α (i.e., Gln^82^, Asn^87^, Thr^153^, Asp^152^, Gln^181^, Tyr^102^, Lys^298^, Ser^184^, Gln^314^, Asn^321^, and Arg^320^) participated in the hydrogen bonding with the TSGA10 domain. The average length of hydrogen bonds between the docked proteins was about 2.91 Å.

Prediction of subcellular localization {#s3-5}
--------------------------------------

Subcellular localization of the TSGA10 and HIF-1α proteins are reported based on the database annotation (UniProtKB, Ensembl, GOC, CAFA, BHF-UCL, MGI, and HPA). These proteins showed a wide variety of adjacent subcellular localizations ([Fig. 6](#F6){ref-type="fig"}). In this regard, based on the predicted confidence scores (0-5), the TSGA10 protein is mainly localized in the cell nucleus, and the HIF-1α is mainly localized in the nucleus and cytoplasm.
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PPI network topological analysis {#s3-6}
--------------------------------

Topological and functional enrichment analysis of the generated PPI network was performed by means of the Network Analyzer plugin of Cytoscape that provided network radius and diameter ([Table 2](#T2){ref-type="table"}). In the PPI network, the average degree of each node and average of local clustering coefficient was calculated as 13.6 and 0.67, respectively. The degree distribution and clustering coefficient plots in the constructed PPI network were as a power law, therefore the network can be referred to as a scale-free network (Figs. S2 and S3).

###### The topological parameters of the constructed PPI network

  ----------------------------- ------------
  **Topology parameters**       **Amount**
  Number of nodes               57
  Network density               0.242
  Network heterogeneity         0.636
  Isolated nodes                0
  Number of self-loops          0
  Multi-edge node pairs         0
  Clustering coefficient        0.635
  Connected components          1
  Network diameter              4
  Network radius                2
  Network centralization        0.470
  Shortest paths                3192
  Average number of neighbors   13.579
  Characteristic path length    2.053
  ----------------------------- ------------

In [Table 3](#T3){ref-type="table"} , the top ten most connected nodes (hubs) are ranked based on different scoring algorithms of CytoHubba plugin. The consensus hubs into the PPI network are separately indicated. The MCC method provides a more accurate predicting performance than the other algorithms.^[@R41]^ Integration of nine topological scoring approaches was used for the precise selection of the best hubs in this scale-free network.

###### The list of top 10 hubs obtained by employing the nine different types of scoring algorithms of CytoHubba plugin

  ----------------- -------------------- ------------------- --------------- ------------------ ---------- ------------ --------------- ------------ ---------- ----------
  **Rank**          **Scoring method**   **Consensus** ^a^                                                                                                      
  **Betweenness**   **MNC**              **Bottleneck**      **Radiality**   **EcCentricity**   **MCC**    **Stress**   **Closeness**   **Degree**              
  1                 HIF-1α               HIF1- α             HIF-1α          HIF-1α             TSGA10     VEGFA        HSP90AA1        HIF-1α       HIF-1α     HIF-1α
  2                 HSP90AA1             VEGFA               VEGFA           VEGFA              TEKT3      HIF-1α       HIF-1α          VEGFA        VEGFA      VEGFA
  3                 TSGA10               ARNT                HSP90AA1        ARNT               LOC81691   TP53         AKT1            ARNT         ARNT       HSP90AA1
  4                 AKT1                 AKT1                TSGA10          HSP90AA1           SPAG6      AKT1         VEGFA           HSP90AA1     HSP90AA1   AKT1
  5                 ARNT                 HSP90AA1            APP             AKT1               TUBA3C     JUN          ARNT            AKT1         AKT1       ARNT
  6                 VEGFA                TP53                TP53            TP53               BACE1      EP300        TSGA10          TP53         TP53       TP53
  7                 TUPA3C               VHL                 SPAG6           JUN                HIF-1α     EGFR         APP             VHL          VHL        TSGA10
  8                 SPAG6                JUN                 TUBB4B          EGFR               CXCR4      CDKN1A       VHL             JUN          JUN        VHL
  9                 APP                  EGFR                AKT1            VHL                ADM        MDM2         NOTCH1          EGFR         EGFR       JUN
  10                VHL                  EPO                 FLT1            EP300              BHLHE41    HSP90AA1     TP53            EP300        EPO        EGFR
  ----------------- -------------------- ------------------- --------------- ------------------ ---------- ------------ --------------- ------------ ---------- ----------

MNC: maximum neighborhood component; MCC: maximal clique centrality.

^a^ The final consensus protein hubs are ranked as 1 (as the highest) to 10 (the lowest).

The consensus hubs (CoHbs) can play a central role in the network clustering that reveals the active sub-networks (module) as they are involved in the crucial cellular functions into the PPI network. Moreover, deletion of the CoHbs may destroy the PPI network, leading to the basic disorders in the cellular homeostasis. In [Fig. 7](#F7){ref-type="fig"} , the topology of CoHbs is visible based on their score.
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Network clustering analysis {#s3-7}
---------------------------

For the detection of the network clusters, we used the MCODE plugin that is taken from the Cytoscape. The result of MCODE revealed three main network clusters ([Fig. 8](#F8){ref-type="fig"}).
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In addition, the CoHbs were imported to the functional annotation clustering tool of DAVID for the analysis of biological pathways, molecular function (MF), and biological process (BP) of TSGA10, HIF-1α. [Table 4](#T4){ref-type="table"} represents the selected top three clusters with more enrichment score and a *P*-value less than 0.05. In the third cluster, TSGA10 and HIF-1α were located in the same cluster and showed the same keyword (nucleus and phosphoprotein).

###### List of functional clusters with a co-occurrence meaning the biological pathways common between the THCNs

  ---------------------------- --------------------------------------------------------------------------------------------------- -------------------- ----------- -------------------------------------------------------------
  **Annotation cluster 1**                                                                                                                                          
  **Enrichment score 5.91**                                                                                                                                         
  **Category**                 **Term**                                                                                            ***P-*** **value**   **Count**   **Genes**
  KEGG_PATHWAY                 Renal cell carcinoma                                                                                3.45E-09             6           *ARNT, JUN, VHL, HIF-1α, VEGFA, AKT1,*
  BIOCARTA                     Hypoxia-Inducible Factor in the cardiovascular system                                               3.62E-09             6           *ARNT, HSP90AA1, JUN, VHL, HIF-1α, VEGFA*
  KEGG_PATHWAY                 HIF-1α signaling pathway                                                                            2.80E-08             6           *ARNT, VHL, HIF-1α, VEGFA, EGFR, AKT1*
  GOTERM_BP_DIRECT             Regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)     3.46E-07             4           *ARNT, VHL, HIF-1α, VEGFA*
  GOTERM_BP_DIRECT             Positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949)   3.05E-05             3           *ARNT, HIF-1α, VEGFA*
  BIOCARTA                     VEGF, Hypoxia, and Angiogenesis                                                                     3.30E-04             4           *ARNT, VHL, HIF-1α, VEGFA*
  GOTERM_BP_DIRECT             Response to hypoxia (GO:0001666)                                                                    0.004                3           *ARNT, HIF-1α, VEGFA*
  **Annotation cluster 2**                                                                                                                                          
  **Enrichment score: 4.43**                                                                                                                                        
  **Category**                 **Term**                                                                                            ***P*** **-value**   **Count**   **Genes**
  GOTERM_BP_DIRECT             Positive regulation of endothelial cell proliferation (GO:0001938)                                  3.24E-08             5           *ARNT, JUN, HIF-1α, VEGFA, AKT1*
  GOTERM_BP_DIRECT             Outflow tract morphogenesis (GO:0003151)                                                            0.0003               3           *JUN, HIF-1α, VEGFA*
  GOTERM_BP_DIRECT             Angiogenesis (GO:0001525)                                                                           0.006                3           *JUN, HIF-1α, VEGFA*
  **Annotation cluster 3**                                                                                                                                          
  **Enrichment score: 3.16**                                                                                                                                        
  **Category**                 **Term**                                                                                            ***P*** **-value**   **Count**   **Genes**
  KEGG_PATHWAY                 Pathways in cancer (hsa05200)                                                                       1.02E-10             9           *TP53, ARNT, HSP90AA1, JUN, VHL, HIF-1α, VEGFA, EGFR, AKT1*
  GOTERM_MF_DIRECT             Enzyme binding (GO:0019899)                                                                         3.42E-07             6           *TP53, JUN, VHL, HIF-1α, EGFR, AKT1*
  UP_KEYWORDS                  Ubl conjugation                                                                                     3.68E-04             6           *TP53, HSP90AA1, JUN, HIF-1α, EGFR, AKT1*
  GOTERM_CC_DIRECT             Nucleoplasm (GO:0005654)                                                                            6.99E-04             7           *TP53, ARNT, HSP90AA1, JUN, VHL, HIF-1α, AKT1*
  UP_KEYWORDS                  Nucleus                                                                                             0.0016               8           *TP53, ARNT, JUN, VHL, HIF-1α, TSGA10, EGFR, AKT1*
  GOTERM_CC_DIRECT             Nucleus (GO:0005634)                                                                                0.004                8           *TP53, ARNT, HSP90AA1, JUN, VHL, HIF-1α, EGFR, AKT1*
  UP_KEYWORDS                  Acetylation                                                                                         0.009                6           *TP53, ARNT, HSP90AA1, JUN, HIF-1α, AKT1*
  GOTERM_CC_DIRECT             Cytosol (GO:0005829)                                                                                0.013                6           *TP53, HSP90AA1, JUN, VHL, HIF-1α, AKT1*
  UP_KEYWORDS                  Phosphoprotein                                                                                      0.025                8           *TP53, ARNT, HSP90AA1, JUN, HIF-1α, TSGA10, EGFR, AKT1*
  ---------------------------- --------------------------------------------------------------------------------------------------- -------------------- ----------- -------------------------------------------------------------

BP: biological process; MF: molecular function; CC: cellular component. GO: Gene ontology.

Annotation of the functional modules {#s3-8}
------------------------------------

In this part, the modularity feature of the constructed PPI network was applied for identifying the coordinated biological functions or processes of TSGA10 and HIF-1α. In the current work, the PPIs were analyzed by using the molecular docking ([Fig. 4](#F4){ref-type="fig"}), and the network modularity analysis ([Fig. 9](#F9){ref-type="fig"}). In the PPI network, we detected three large modules and two small modules by applying the network module finding algorithm jActiveModule. The interesting point in these functional modules is the simultaneous presence of both HIF-1α and TSGA10 in the extracted modules. These finding proposed an interpretable physical interaction between HIF-1α and TSGA10, and also manifested the key role of this protein pairs into the functional modules. The cellular component (CC), molecular function (MF), and biological process (BP) ontology of the topological large modules help us to understand the interactions between all the proteins into the functional modules. The data about the CC, MF, and BP ontology are provided in Tables S1, S2, and S3, respectively.
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Moreover, the nodes of each large module were mapped based on the sequence feature and the use of the DAVID online tool to find the functional categories. The functional category of each node in the modules is listed in Table S4. In this functional enrichment analysis, it was annotated that there is a significant physical interaction between TSGA10 and HIF-1α (Table S4).

Rebuilding the signaling pathways {#s3-9}
---------------------------------

Based on our findings, there are several crucial paths, including PI3/AKT/mTOR as well as HIF-1α activation (in hypoxia) and inhibition (in normoxia). Based on the docking data, as well as the network and the functional enrichment analyses, we reconstructed the HIF-1α signaling pathway with adding the TSGA10 protein as an inhibitory factor in the formation of HIF-1α/P300/CBP transcription complex. [Fig. 10](#F10){ref-type="fig"} represents the main cellular events that occur subsequent to hypoxia and HIF-1α activation (e.g., angiogenesis, pH dysregulation, cell migration, and metastasis), normoxia (ubiquitin-mediated HIF-1α complex degradation) and TSGA10 activation (e.g., inhibition the HIF-1α/HIF-1β/P300-CBP complex activation).
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Discussion {#s4}
==========

To date, it has been recognized that malignancies, in particular, solid tumors, possess a unique energetic metabolism profile, upon which they are able to regulate their growth and progression, in large part based on the aberrant usage of glucose and oxygen.^[@R45]^ In the nutrient starvation and oxygen constraints, the cancer cells compete with normal cells for the vital elements. Distribution of produced metabolites will be irregular due to the high number of cells in the tumor mass, while pH dysregulation will occur within the TME. In such circumstances, cancer cells release the primary factors that are involved in the angiogenesis, which in turn, guarantee the survival and uncontrolled proliferation of the cancerous cells. On the other hand, various bio-elements involved in the regulation of intracellular pH (pH~i~) are activated to modulate the pH~i~ alterations. Phenotypically, such phenomena result in the alkalinization of cancer cells cytoplasm, extracellular acidification, and activation of extracellular matrix-degrading enzymes.^[@R16],[@R46]^ Here, for the first time, we evaluated the expression of *TSGA10* at the level of mRNA and protein under the normoxic and hypoxic conditions *in vitro*, and then computationally analyzed its interaction with HIF-1α as its main functional partner.

Hypoxia (oxygen deficiency) is one of the main features of solid tumors, in which the HIF-1 as an important transcription factor plays a central role in the energetic pathways of cancer cells and hence the formation of TME. In fact, HIF-1 can bind to the hypoxic response elements (HREs), leading to the expression of the necessary genes to compromise with the hypoxia.^[@R47]^ During the hypoxia in TME, the ubiquitin-mediated degradation of HIF-1 subunits are inhibited, the HIF-1 activation cascade is triggered, and then HIF-1 transcription complex is linked to the HREs. This transcription initiation complex is formed by the dimerization of HIF-1 subunits (HIF-1α/HIF-1β), and then it is stabilized by binding the CBP/P300/Ref-1 coactivators, leading to the formation of transcription initiation complex. As a result, several different pathophysiological phenotypes such as pH dysregulation, angiogenesis, and cell migration can emerge. These coactivators, along with some other factors, seem to facilitate the accessibility of RNA polymerase for high quality and quantity transcription activity of the cell.^[@R48]^ The heterodimeric HIF-1 (HIF-1α/HIF-1β) has also three functional subunits, including (i) PER-ARNT-SIM (PAS), (ii) helix-loop-helix (HLH), and (iii) N- and C-terminal transactivation domains (C-TAD, N-TAD),^[@R49],[@R50]^ of these, the HLH subunit and PAS domains (A and B) contribute to the HIF-1 dimerization, while the transactivation domains are associated with the transcriptional activity of HIF-1, and the C-TAD is involved in the interaction with CBP/P300 molecules under the hypoxia.^[@R19],[@R51]^ Among different regulatory factors, *TSGA10* seems to have a potential regulatory role in the activity of HIF-1α.^[@R52]^ On the basis of the functional expression of *TSGA10* in the adult human testis, some biological functions (e.g., cell division, differentiation, and migration of embryonic tissues) seem to be attributed to its functional expression.^[@R9],[@R53]^ Further, it was reported that *TSGA10* is overexpressed in brain tumors (83%), breast cancers (66%), gastrointestinal tract tumors (58%), as well as skin (66%) and soft tissue tumors (53%).^[@R54]^ *TSGA10* interaction with HIF-1α was shown to prevent the nuclear localization and transcriptional activity of the HIF-1α.^[@R22],[@R55]^ Because of the important role of *TSGA10* in the cell proliferation, it is supposed to be a key player in the survival and growth of cancer cells, which can also serve as a tumor marker in solid tumors such as breast cancer.^[@R8]^ Hagele and co-workers founded that there exists a prominent subcellular localization pattern for *TSGA10* and HIF-1α in the tail of spermatozoa, in which the *TSGA10* seems to prevent the nuclear localization and transcription activity of HIF-1α. They indicated that the N-terminal domain of HIF-1α can physically interact with the C-terminal domain of *TSGA10*.^[@R22]^ However, the impact of the interaction of HIF-1α with *TSGA10* in progression or suppression of cancer seems to be unclear. Our findings revealed that the MDA-MB-231 and MCF-7 cells treated with low glucose under hypoxic condition could improve their proliferation and motility, indicating hypoxia as a key player in terms of the breast cancer metastasis ([Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Further, *TSGA10* seems to function as an inhibitor of metastasis and migration in the breast cancer MDA-MB-231 cells ([Fig. 3](#F3){ref-type="fig"}). In the current study, we also used molecular docking approaches to analyze the interaction between *TSGA10* and HIF-1α. The docking energy (-698.69 kcal/mol), an average of hydrogen bonds (2.91 Å), and the number of hydrophobic bonds showed that there is a high-affinity interaction between these proteins ([Figs. 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Our result is in agreement with that of the previously published work conducted by Mansouri et al.^[@R52]^ They showed that the C-TAD domain of HIF-1α has a strong binding affinity to the C-terminal domain of *TSGA10*. They also reported the inhibitory role of *TSGA10* on the HIF-1α dimerization, at which it leads to the inactivation of HIF-1α through the inhibition of CBP/P300 co-activators. Altogether, *TSGA10* has an inhibitory effect on the cell growth, angiogenesis, migration, and metastasis, for which the HIF-1α seems to function as a provocative factor.^[@R52]^ While the *TSGA10* is mainly localized in the cell nucleus, the HIF-1α seems to be abundantly localized in the nucleus and cytoplasm of the cells (Fig. 6), hence their functions differ dramatically. We reconstructed these biological paths using the CellDesigner software.

Our results in 24 hours showed that the expression of *TSGA10* gene increases when the migration of cells is low. In other words, at the early stages of cancer progression, the *TSGA10* might impose a suppressive impact. However, with the increase of intracellular metabolites and disruption of pH homeostasis, *TSGA10* cannot play a controlling role anymore and perhaps after this stage, it either acts oppositely provoking the progression of cancer cells, or its functional expression is stopped. Due to the lack of data and also the paradoxical observations in previous reports, further studies need to be accomplished to address the actual impacts of *TSGA10* in the progression of cancer. Unlike some previously reported studies,^[@R11],[@R12]^ the expression level of *TSGA10* in most of the human cancers is increased in comparison with the normal cells (<https://cancergenome.nih.gov/>). As we know, the level of mRNA cannot be considered as a measure of the protein levels. Therefore, to clarify the genetic function and mechanisms of the disease, a combination of genomics and proteomics experiments is expected to provide a better understanding. Based on our findings, an increased expression of *TSGA10* appears to lead to a decrease in the migration and metastasis of cancer cells. In the high concentrations of glucose, in which solid tumors have good nutrients and grow extremely well, the expression of *TSGA10* is speculated to possibly prevent the aggressive phenotypes. Under such conditions, we also applied hypoxia to mimic the TME and found an increased expression of the *TSGA10* gene. Furthermore, the PPI network analysis of *TSGA10* and HIF-1α resulted in 57 nodes and 387 edges ([Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}). Then, we clustered the network into the functional and topological sub-network modules ([Figs. 7](#F7){ref-type="fig"}, [8](#F8){ref-type="fig"}, and [9](#F9){ref-type="fig"}). In the systems-based approaches, we aimed to annotate the topological modules at the network level and by using the gene ontology enrichment analysis. In several studies, it has been shown that the modulation of PPI networks together with detection of highly connected hubs and interaction modules can result in possible detection/verification of less-known/unknown molecular functions, biological pathways, cellular localization, as well as cellular markers and antigens.^[@R56],[@R57]^ Such findings may result in the detection of biomarkers and candidate antigens for the future works such as drug and vaccine designing,^[@R58]^ as well as mechanisms underlying diseases initiation and progression ([Fig. 9](#F9){ref-type="fig"}). Moreover, the highly connected nodes have the main role in the organization of the bio-molecular networks.^[@R59]^ This type of analysis is on the basis of "guilt-by-association" concept. Taken all together, the network modulation resulted in the detection of three major functional modules ([Fig. 9](#F9){ref-type="fig"}), and TSGA10 and HIF-1α proteins located in the same modules (Fig. 10). As reported recently, the proteins that interact with each other tend likely to be co-localized in the adjacent cellular compartments.^[@R60]^ Therefore, we used the GO-based annotation of these modules, and we observed these proteins represented as an interacting partner.

Conclusion {#s5}
==========

In our integrative analysis (wet- and dry-lab assays), we showed the expression behavior of *TSGA10* in hypoxia and then constructed a PPI network of *TSGA10* and HIF-1α and detected its functional modules. The *in vitro* and *in silico* analyses clearly represented a possible functional association between *TSGA10* and HIF-1α proteins. We envision that the hub nodes of these modules (HIF-1α, *ARNT*, *VEGFA*, *AKT1*, *TSGA10*, *HSP90AA1*, *VHL,* and *JUN*) can be served as candidate biomarkers for the chemotherapy, vaccine, or immunotherapy interventions.
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Research Highlights {#s12}
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What is the current knowledge? {#Res1}
------------------------------

1.  **√** Testis-specific gene antigen 10 (*TSGA10*) is a less-known gene involved in the vague biological paths of different cancers.

What is new here? {#Re2}
-----------------

1.  **√** The increased expression of *TSGA10* was found to be significantly associated with the reduced metastasis in the MDA-MB-231cells.

2.  **√** There is an inverse relationship between the *TSGA10* mRNA level and the cellular migration in the MDA-MB-231cells.

3.  **√** The C-terminal domain of *TSGA10* can interact with HIF-1α with high affinity, which might associate with some key interation nodes (i.e., HIF-1α, *VEGFA*, *HSP90AA1*, *AKT1*, *ARNT*, *TP53*, *TSGA10*, *VHL*, *JUN*, and *EGFR*).

4.  **√** TSGA10 functional expression alters under the hyper-/hypo-glycemia and hypoxia.
